Recursion Pharmaceuticals (RXRX) Change in Receivables (2020 - 2021)
Recursion Pharmaceuticals (RXRX) reported Change in Receivables of -$16000.0 for Q3 2021, down 100.05% on a YoY basis from $30.2 million in Q3 2020, and down 23.08% quarter-over-quarter from -$13000.0 in Q2 2021.
Recursion Pharmaceuticals (RXRX) Change in Receivables (2020 - 2021) Analysis & Trends
Recursion Pharmaceuticals has reported Change in Receivables for 2 years, with the latest figure at -$16000.0 in Q3 2021.
- For the quarter ending Q3 2021, Change in Receivables fell 100.05% year-over-year to -$16000.0; the trailing twelve-month figure through Dec 2021 stood at -$114000.0 (down 2380.0% YoY), and the FY2021 full-year result was -$114000.0, down 2380.0% from the prior year.
- Change in Receivables for Q3 2021 stood at -$16000.0, down from -$13000.0 in the prior quarter.
- The five-year high for Change in Receivables was $30.2 million in Q3 2020, with the low at -$30.0 million in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 22,529.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -39.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -4.08 Mn |
| 10 | Recursion Pharmaceuticals | 1.71 Bn | 1.05 Bn | -6.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | -16,000.00 |
| Sep 30, 2021 | -16,000.00 |
| Jun 30, 2021 | -13,000.00 |
| Jun 30, 2021 | -13,000.00 |
| Mar 31, 2021 | -85,000.00 |
| Mar 31, 2021 | -85,000.00 |
| Dec 31, 2020 | -30.04 Mn |
| Dec 31, 2020 | -30.04 Mn |
| Sep 30, 2020 | 30.19 Mn |
| Sep 30, 2020 | 30.19 Mn |
| Jun 30, 2020 | -60,000.00 |
| Jun 30, 2020 | -60,000.00 |
| Mar 31, 2020 | -82,000.00 |
| Mar 31, 2020 | -82,000.00 |